期刊文献+

具有蛋白酶及解旋酶活性的HCV-NS3重组蛋白的纯化及活性分析

Purification and Enzymatic Analysis of the Recombinant Hepatitis C Virus NonStructure Protein 3 with Protease and Helicase Activity
下载PDF
导出
摘要 为深入探讨HCV-NS3蛋白的酶动力学性质,制备了具有蛋白酶及解旋酶活性的HCVNS3重组蛋白。利用PCR扩增HCV非结构基因NS3,插入pPIC9,测序分析。携带NS3基因的重组质粒(pPIC9-NS3)转化毕氏酵母菌菌株GS115,甲醇诱导表达NS3蛋白。重组蛋白首先采用Hitrapchelating柱进行亲和分离,之后使用MonoSHR柱进一步纯化。对纯化后的NS3重组蛋白的酶活性进行分析,结果表明,获得的重组蛋白分别具有蛋白酶及解旋酶活性。本研究为深入探讨NS3编码酶的功能和开发抗病毒药物创造条件。 To study the enzymatic activity,the recombinant HCV NS3 protein with both protease and helicase activity was expressed and purified. The nonstructure gene 3 (NS3) of HCV was amplified and inserted into plasmid pPIC9 and the recombinant plasmid pPIC-NS3 was transformed into Pichia pastoris strain GS115. Recombinant protein was produced by induction of the AOX1 promoter with methanol. The recombinant protein was first purified by Hitrap SP cation exchange and then by Mono S HR column. In vitro cleavage assay showed that the recombinant protein has protease and helicase activity.
出处 《中国病毒学》 CAS CSCD 2004年第4期325-328,共4页 Virologica Sinica
关键词 丙型肝炎病毒 非结构蛋白3 纯化 酶活性 重组蛋白 Hepatitis C virus (HCV) Non structure protein 3 Purification,Enzymatic activity analysis
  • 相关文献

参考文献7

  • 1Borowski P, Schalinski S, Schmitz H. Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy[J].Antiviral Res, 2002, 55: 397-412.
  • 2Portal-Nunez S, Gonzalez-Navarro C J, Garcia-Delgado M, et al.Peptide inhibitors of hepatitis C virus NS3 protease[J]. Antivir Chem Chemother, 2003, 14: 225-233.
  • 3Frick D N. Helicases as antiviral drug targets Drug[J]. News Perspect,2003, 16: 355-362.
  • 4Kim, D. W, Y. Gwack, J. H. Han, et al. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity[J].Biochem. Biophys. Res. Commol/Lun, 1995, 215: 160-166.
  • 5Grakoui A, McCourt D W, Wychowski C, et al. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites[J]. J Virol, 1993, 67:2832-2843
  • 6Lamarre D, Anderson P C, Bailey M, et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus[J].Nature, 2003, 426:186-189.
  • 7Nizi E, Koch U, Ponzi S, et al. Capped dipeptide alpha-ketoacid inhibitors of the HCV NS3 protease[J]. Bioorg Med Chem Lett, 2002,12: 3325-3328.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部